Module 05b. Cardiovascular PET Tracers - Part b-Myocardial Inflammation, Viability, and Amyloid Imaging (Slides)

Myocardial Inflammation, Viability, and Amyloid Imaging (Slides)

Pdf Summary

This document is a module on cardiovascular PET tracers, specifically focusing on myocardial inflammation, viability, and amyloid imaging. It provides information on the principles, protocols, interpretation, and clinical applications of cardiac PET imaging using various tracers.<br /><br />The module emphasizes the use of 18F-FDG PET for cardiac sarcoidosis, myocardial viability, amyloidosis, and infection. It suggests that FDG cardiac PET should be considered in patients with abnormal screening for cardiac sarcoidosis, unexplained conduction disease in patients younger than 60, idiopathic sustained ventricular tachycardia, and proven cardiac sarcoidosis for treatment follow-up.<br /><br />The module also provides dietary preparation guidelines for patients undergoing PET imaging, including fasting and avoiding foods containing carbohydrates and sugars. Clear liquids, coffee, tea, and water are allowed during fasting.<br /><br />Several case examples are presented, demonstrating the use of FDG PET in diagnosing sarcoidosis and other conditions. The module includes images and references for further reading.<br /><br />Overall, the module highlights the clinical utility and benefits of PET imaging in evaluating myocardial inflammation, viability, amyloidosis, and infection. It emphasizes the importance of proper patient preparation and provides practical guidelines for performing these imaging studies.

Keywords

cardiovascular PET tracers

myocardial inflammation

viability

amyloid imaging

18F-FDG PET

cardiac sarcoidosis

myocardial viability

amyloidosis

infection

dietary preparation guidelines